Skip to content

Omnicell OMCL Free cash flow margin

Free cash flow margin at other companies

Baxter International logo
Baxter InternationalBAX
3%-2.4pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
16.4%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
3%
Cardinal Health logo
Cardinal HealthCAH
1.7%+0.6pp
Cencora logo
CencoraCOR
1.1%+1.0pp
ICU Medical logo
ICU MedicalICUI
4.2%-1.2pp

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.75B-7.2%
Enterprise value$1.49B-0.4%
P/E113.2×
P/S1.4×-0.2×

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Calculated from Omnicell’s reported figures.

Based on trailing twelve months.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's free cash flow margin?
Omnicell (OMCL) reported free cash flow margin of 9.3% in Q1 2026.
How has Omnicell's free cash flow margin changed year-over-year?
Omnicell's free cash flow margin decreased by 15.3% year-over-year, from 11% to 9.3%.
What is the long-term trend for Omnicell's free cash flow margin?
Over 5 years (2020 to 2025), Omnicell's free cash flow margin has grown at a -16.7% compound annual growth rate (CAGR), from 18.3% to 7.3%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.